Trends and implications of antimicrobial resistance in Pseudomonas aeruginosa: Insights from a 19-year study in Zhejiang Province

Ju Li,Yunkang Wang,Pei Liu,Yuanqing Zhang,Yufan Yang,Shuang Zhao,Junfeng He,Cheng Zhao,Xu Jia,Lin Zhang
DOI: https://doi.org/10.1097/md.0000000000040606
IF: 1.6
2024-11-28
Medicine
Abstract:Pseudomonas aeruginosa ( P. aeruginosa , PA) is a Gram-negative opportunistic pathogen prevalent in both natural environments and hospital settings. It is notorious for its robust intrinsic and acquired resistance mechanisms, including the production of antibacterial inactivating enzymes such as beta-lactamase, which contribute to its role as a primary and secondary infectious agent. [ 1–3 ] This pathogen can cause a range of infections, such as respiratory tract infections in COPD, urinary tract infections, and skin and soft tissue infections, particularly in patients using ventilators or long-term catheters. [ 4 ]
medicine, general & internal
What problem does this paper attempt to address?